Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?
- PMID: 19368628
- DOI: 10.1111/j.1440-1746.2009.05806.x
Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?
Comment on
-
The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.J Gastroenterol Hepatol. 2009 Apr;24(4):564-8. doi: 10.1111/j.1440-1746.2008.05731.x. J Gastroenterol Hepatol. 2009. PMID: 19378390
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
